FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer
Authors
Keywords
Regulatory T cells (Tregs), Colorectal cancer (CRC), Transcription factor forkhead box P3 (FOXP3), Treg-specific demethylated region (TSDR), Epigenetic phenotype, Survival outcome
Journal
IMMUNOLOGIC RESEARCH
Volume 61, Issue 3, Pages 338-347
Publisher
Springer Nature
Online
2015-01-21
DOI
10.1007/s12026-014-8616-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulatory T cells in cancer immunotherapy
- (2014) Hiroyoshi Nishikawa et al. CURRENT OPINION IN IMMUNOLOGY
- Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival
- (2014) Changhua Zhuo et al. Molecular Cancer
- The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer
- (2013) Lequn Li et al. CLINICAL IMMUNOLOGY
- Development and Maintenance of Regulatory T cells
- (2013) Naganari Ohkura et al. IMMUNITY
- Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
- (2013) Giovanni Antonio Maria Povoleri et al. Frontiers in Immunology
- Foxp3+Helios+regulatory T cells are expanded in active systemic lupus erythematosus
- (2012) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development
- (2012) Naganari Ohkura et al. IMMUNITY
- Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer
- (2012) Ivan Shevchenko et al. INTERNATIONAL JOURNAL OF CANCER
- Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome
- (2012) F. Barzaghi et al. JOURNAL OF AUTOIMMUNITY
- Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma: Tumor Interleukin-12 Receptor β2 (IL-12Rβ2), IL-7R, and Stromal FoxP3/CD3 Ratio Are Independent Predictors of Recurrence
- (2012) Kei Suzuki et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+T reg cells
- (2012) Jonathan M. Weiss et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo
- (2012) Mahesh Yadav et al. JOURNAL OF EXPERIMENTAL MEDICINE
- FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency
- (2012) Moritz Peiseler et al. JOURNAL OF HEPATOLOGY
- Runx1 and Runx3 Are Involved in the Generation and Function of Highly Suppressive IL-17-Producing T Regulatory Cells
- (2012) Lequn Li et al. PLoS One
- Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy
- (2012) Adrian Schwarzer et al. PLoS One
- Quantification of Regulatory T Cells in Septic Patients by Real-Time PCR–Based Methylation Assay and Flow Cytometry
- (2012) Roman Tatura et al. PLoS One
- Distribution of regulatory T cells and interaction with dendritic cells in the synovium of rheumatoid arthritis
- (2012) XQ E et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Expression of ROR t Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer
- (2012) N. R. Blatner et al. Science Translational Medicine
- Analysis of Treg Cell Population Alterations in the Peripheral Blood of Patients Treated Surgically for Ovarian Cancer - A Preliminary Report
- (2011) Lukasz Wicherek et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
- (2011) Jiankun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
- (2011) Marie Tosolini et al. CANCER RESEARCH
- Human FoxP3+ CD4+ regulatory T cells: their knowns and unknowns
- (2011) Makoto Miyara et al. IMMUNOLOGY AND CELL BIOLOGY
- Behavior of Circulating CD4+CD25+Foxp3+ Regulatory T Cells in Colon Cancer Patients Undergoing Surgery
- (2011) Ausilia Sellitto et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-17 + Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer
- (2011) Ilona Kryczek et al. JOURNAL OF IMMUNOLOGY
- Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
- (2011) Stephanie A. McClymont et al. JOURNAL OF IMMUNOLOGY
- Synovial and Peripheral Blood CD4+FoxP3+ T Cells in Spondyloarthritis
- (2011) H. APPEL et al. JOURNAL OF RHEUMATOLOGY
- Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions
- (2011) Yeonseok Chung et al. NATURE MEDICINE
- Foxp3+ follicular regulatory T cells control the germinal center response
- (2011) Michelle A Linterman et al. NATURE MEDICINE
- Helios Expression Is a Marker of T Cell Activation and Proliferation
- (2011) Tatiana Akimova et al. PLoS One
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer
- (2010) Won-Suk Lee et al. CANCER
- Regulatory T cells and breast cancer: implications for immunopathogenesis
- (2010) Maria Angelica Ehara Watanabe et al. CANCER AND METASTASIS REVIEWS
- Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents
- (2010) I. J. M. de Vries et al. CLINICAL CANCER RESEARCH
- Inflammation and Colon Cancer
- (2010) Janoš Terzić et al. GASTROENTEROLOGY
- IL-1 -Mediated Signals Preferentially Drive Conversion of Regulatory T Cells but Not Conventional T Cells into IL-17-Producing Cells
- (2010) L. Li et al. JOURNAL OF IMMUNOLOGY
- Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells
- (2010) A. M. Thornton et al. JOURNAL OF IMMUNOLOGY
- Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy
- (2010) Pierpaolo Correale et al. JOURNAL OF IMMUNOTHERAPY
- Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
- (2010) Katsuhiko Nosho et al. JOURNAL OF PATHOLOGY
- Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue
- (2009) G. Wieczorek et al. CANCER RESEARCH
- Increased Intratumoral FOXP3-positive Regulatory Immune Cells during Interleukin-2 Treatment in Metastatic Renal Cell Carcinoma
- (2009) H. K. Jensen et al. CLINICAL CANCER RESEARCH
- Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease
- (2009) Takanori Kanai et al. CURRENT OPINION IN GASTROENTEROLOGY
- Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma
- (2009) Frank A. Sinicrope et al. GASTROENTEROLOGY
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
- (2009) Ethan M. Shevach IMMUNITY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease
- (2009) Nicola Eastaff-Leung et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses
- (2009) Ye Zheng et al. NATURE
- Regulatory T cells exert checks and balances on self tolerance and autoimmunity
- (2009) Kajsa Wing et al. NATURE IMMUNOLOGY
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
- (2009) Meghan A Koch et al. NATURE IMMUNOLOGY
- CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner
- (2009) A. Chaudhry et al. SCIENCE
- High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability
- (2008) S Michel et al. BRITISH JOURNAL OF CANCER
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
- (2008) A. L. Putnam et al. DIABETES
- DC activated via dectin-1 convert Treg into IL-17 producers
- (2008) Fabiola Osorio et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery
- (2008) Tomoki Ito et al. IMMUNITY
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
- (2008) Paul Salama et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuropilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity
- (2008) Yelena Glinka et al. JOURNAL OF LEUKOCYTE BIOLOGY
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
- (2008) Liang Zhou et al. NATURE
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started